CD4 and colorectal carcinoma: Patients with higher estimated proportions of CD4+ T cells, CD8+ T cells and B cells had lower all-cause and CRC-specific mortality, and patients with a higher proportion of neutrophils had higher all-cause and CRC-specific mortality.